Bristol’s CAR-T Strategy Comes Into Focus With Two Near-Term Filings

 
• By Mandy Jackson
  
3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy) - Illustration
Bristol is expanding its CAR-T cell development into new indications.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D